022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Banner
DataBoard Demo
Private Equity | 31 October 2012

GE Capital Acquires Stake In Biocon's Research Arm - Syngene International

by Paritosh Gajjar
GE Capital Acquires Stake In Biocon's Research Arm - Syngene International
Share on Social Media Email Facebook Twitter Linkedin
 
@Paritosh
Kiran Mazumdar Shaw led Biocon is set to receive R125 Cr from GE Equity International Mauritius, a subsidiary of GE Capital Corp. for its research arm, Syngene International Limited.

In return GE Capital would be getting 7.69% equity share in Syngene, a BSE disclosure stated.

Biocon was advised by Allegro Corporate Finance Advisors and Mundkur Law Partners.

Xander To Acquire Stake In Indiabulls Real Estate Arm

Xander To Acquire Stake In Indiabulls Real Estate Arm

Xander Group is in talks with Indiabulls Real Estate to buy 35% stake in its arm Indiabulls InfraEstate for around R800 Cr, according to BS.

Read More...

Deutsche Securities sells Jubilant Life Sciences’ shares for INR122 crore

Deutsche Securities sells Jubilant Life Sciences’ shares for INR122 crore

Deutsche Securities Mauritius Limited has sold its 1.95 percent stake in Jubilant Life Sciences Limited, a global life sciences and pharmaceutical company, for just over INR122 crore. The sale of the stake was performed as an open market transaction, and purchased by Citigroup Global Markets Mauritius Pvt. Ltd.

Read More...
Subscribe
Enter your Email address
to receive all the news